Header Logo

Connection

Lesley Scott to Antitubercular Agents

This is a "connection" page, showing publications Lesley Scott has written about Antitubercular Agents.
Connection Strength

0,735
  1. Delamanid: a review of its use in patients with multidrug-resistant tuberculosis. Drugs. 2015 Jan; 75(1):91-100.
    View in: PubMed
    Score: 0,386
  2. Multicenter feasibility study to assess external quality assessment panels for Xpert MTB/RIF assay in South Africa. J Clin Microbiol. 2014 Jul; 52(7):2493-9.
    View in: PubMed
    Score: 0,092
  3. Diagnostic accuracy of Xpert MTB/RIF for extrapulmonary tuberculosis specimens: establishing a laboratory testing algorithm for South Africa. J Clin Microbiol. 2014 Jun; 52(6):1818-23.
    View in: PubMed
    Score: 0,091
  4. Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South Africa. PLoS One. 2013; 8(6):e65421.
    View in: PubMed
    Score: 0,087
  5. Accuracy of cobas MTB and MTB-RIF/INH for Detection of Mycobacterium tuberculosis and Drug Resistance. J Mol Diagn. 2024 Aug; 26(8):708-718.
    View in: PubMed
    Score: 0,046
  6. Point-of-care Xpert® MTB/RIF for smear-negative tuberculosis suspects at a primary care clinic in South Africa. Int J Tuberc Lung Dis. 2013 Mar; 17(3):368-72.
    View in: PubMed
    Score: 0,021
  7. Tuberculosis in east timorese refugees: implications for health care needs in East Timor. Int J Tuberc Lung Dis. 2002 Nov; 6(11):980-7.
    View in: PubMed
    Score: 0,010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.